Results: 1-25 | 26-50 | 51-72 |
Results: 51-72/72

Authors: ZANCHETTI A HANSSON L MENARD J RAMSAY LE LARAGH JH
Citation: A. Zanchetti et al., ROUND-TABLE-2 - A CRITIQUE OF THE 5TH JOINT NATIONAL COMMITTEE REPORTIN DETECTION, EVALUATION AND TREATMENT OF HIGH BLOOD-PRESSURE - DISCUSSION, Journal of hypertension, 11, 1993, pp. 190000389-190000394

Authors: HAQ IU MINNIS RC JACKSON PR YEO WW RAMSAY LE
Citation: Iu. Haq et al., SECONDARY PREVENTION IN CORONARY HEART-DISEASE, Journal of human nutrition and dietetics, 9(5), 1996, pp. 363-371

Authors: JACKSON PR YEO WW CHADWICK IG RAMSAY LE
Citation: Pr. Jackson et al., SELF-MONITORING OF TRIGLYCERIDE CONCENTRATIONS - INAPPROPRIATE ANALYSIS, BMJ. British medical journal, 306(6886), 1993, pp. 1198-1198

Authors: GHAHRAMANI P HAQ IU YEO WW JACKSON PR RAMSAY LE
Citation: P. Ghahramani et al., SHEFFIELD CARDIOVASCULAR RISK PROGRAM FOR TARGETING STATIN TREATMENT - SCRIPTS FOR ROUTINE USE IN GENERAL-PRACTICE, Hypertension, 32(4), 1998, pp. 2-2

Authors: HAQ IU JACKSON PR YEO WW RAMSAY LE
Citation: Iu. Haq et al., SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE, Lancet, 346(8988), 1995, pp. 1467-1471

Authors: HAQ IU JACKSON PR YEO WW RAMSAY LE
Citation: Iu. Haq et al., SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING IN PREVENTION OF CORONARY HEART-DISEASE - REPLY, Lancet, 347(8999), 1996, pp. 468-469

Authors: RAMSAY LE HAQ IU JACKSON PR YEO WW
Citation: Le. Ramsay et al., SHEFFIELD RISK AND TREATMENT TABLE FOR PRIMARY PREVENTION OF CORONARYHEART-DISEASE - REPLY, Lancet, 348(9033), 1996, pp. 1040-1041

Authors: HAQ IU YEE WW JACKSON PR RAMSAY LE
Citation: Iu. Haq et al., SHOULD CHOLESTEROL BE MEASURED IN ALL HYPERTENSIVES, Journal of human hypertension, 9(6), 1995, pp. 417-421

Authors: WALLIS EJ RAMSAY LE YEO WW JACKSON PR
Citation: Ej. Wallis et al., STATINS FOR PREVENTION OF STROKE, Lancet, 352(9131), 1998, pp. 909-910

Authors: RAMSAY LE HAQ IU JACKSON PR YEO WW PICKIN DM PAYNE JN
Citation: Le. Ramsay et al., TARGETING LIPID-LOWERING DRUG-THERAPY FOR PRIMARY PREVENTION OF CORONARY-DISEASE - AN UPDATED SHEFFIELD TABLE, Lancet, 348(9024), 1996, pp. 387-388

Authors: RAMSAY LE HAQ IU JACKSON PR YEO WW
Citation: Le. Ramsay et al., TARGETING LIPID-LOWERING DRUG-THERAPY FOR PRIMARY PREVENTION OF CORONARY HEART-DISEASE - AN UPDATED SHEFFIELD TABLE (VOL 348, PG 387, 1996), Lancet, 348(9036), 1996, pp. 1251-1252

Authors: HAQ IU YEO WW JACKSON PR RAMSAY LE
Citation: Iu. Haq et al., THE EFFECTS OF DIETARY CHANGE ON SERUM-CHOLESTEROL, Proceedings of the Nutrition Society, 54(3), 1995, pp. 601-616

Authors: RAMSAY LE
Citation: Le. Ramsay, THE HYPERTENSION DETECTION AND FOLLOW-UP PROGRAM - 17 YEARS ON, JAMA, the journal of the American Medical Association, 277(2), 1997, pp. 167-170

Authors: JACKSON PR HAQ IU WALLIS EJ YEO WW RAMSAY LE
Citation: Pr. Jackson et al., THE IMPACT OF AMBULATORY BLOOD-PRESSURE ON ESTIMATION OF CARDIOVASCULAR RISK IN MILD HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27105-27105

Authors: SCHELLING A RAMSAY LE FREYTAG F
Citation: A. Schelling et al., THE LONG-TERM SAFETY AND EFFICACY OF TELMISARTAN COMPARED TO ATENOLOLIN THE TREATMENT OF HYPERTENSION, Journal of hypertension, 16, 1998, pp. 27096-27096

Authors: ULHAQ I JACKSON PR YEO WW RAMSAY LE
Citation: I. Ulhaq et al., THE POSSIBLE NEED FOR HMG COA REDUCTASE INHIBITOR TREATMENT IN HYPERTENSIVE PATIENTS FOR PREVENTION OF CORONARY HEART-DISEASE IN THE UK POPULATION, Hypertension, 28(4), 1996, pp. 699-699

Authors: RAMSAY LE WALLIS EJ YEO WM JACKSON PR
Citation: Le. Ramsay et al., THE RATIONALE FOR DIFFERING NATIONAL RECOMMENDATIONS FOR THE TREATMENT OF HYPERTENSION, American journal of hypertension, 11(6), 1998, pp. 79-88

Authors: LEVER AF RAMSAY LE
Citation: Af. Lever et Le. Ramsay, TREATMENT OF HYPERTENSION IN THE ELDERLY, Journal of hypertension, 13(6), 1995, pp. 571-579

Authors: HAQ IU HOUGH RE YEO WW JACKSON PR RAMSAY LE
Citation: Iu. Haq et al., TREATMENT OF UNCOMPLICATED MILD HYPERTENSION - REAPPRAISAL OF THE RISK-BASED APPROACH, Hypertension, 30(4), 1997, pp. 22-22

Authors: WALLIS EJ RAMSAY LE YEO WW JACKSON PR PICKIN M HAQ IU
Citation: Ej. Wallis et al., USE OF STATINS - EVIDENCE ON EFFECTIVENESS IS STRONGER FOR STATINS THAN FOR OTHER TREATMENTS, BMJ. British medical journal, 315(7122), 1997, pp. 1618-1619

Authors: RAMSAY LE WALLIS EJ HAQ IU WILLIAMSON R YEO WW JACKSON PR
Citation: Le. Ramsay et al., USE OF STATINS - SHEFFIELD TABLE IS USEFUL, BMJ. British medical journal, 317(7156), 1998, pp. 473-474

Authors: DAVIES SJC GHAHRAMANI P PALMER RL HIPPISLEYCOX J JACKSON PR YEO WW RAMSAY LE
Citation: Sjc. Davies et al., WHITE-COAT EFFECT IN RESISTANT AND NON-RESISTANT HYPERTENSION - A CASE-CONTROL STUDY, Hypertension, 30(4), 1997, pp. 60-60
Risultati: 1-25 | 26-50 | 51-72 |